Abstract: A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno-compromised host being treated with a bone marrow transplantation.
Type:
Application
Filed:
May 29, 2012
Publication date:
November 22, 2012
Applicant:
SCICLONE PHARMACEUTICALS, INC.
Inventors:
Guido RASI, Enrico GARACI, Francesco BISTONI, Luigina ROMANI, Paolo Di Francesco
© 2024 Justia
